Condition: Sepsis - to Reduce Mortality in the Intensive Care Unit · Sepsis · Septic Shock · Sponsor: Erasmus Medical Center
The aim of this study is to investigate if an initial short double dose of beta-lactam antibiotics will reduce mortality in critically ill patients with sepsis.
This description comes directly from the study's public registry record.
Birgit C.P. Koch, PharmD · 0031107033202 · b.koch@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Maasstad Ziekenhuis | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06766461